Immune System, Friend or Foe of Oncolytic Virotherapy?-Reference-Cited by-同舟云学术

Immune System, Friend or Foe of Oncolytic Virotherapy?

Published:2017-05-23 Issue: Volume:7 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Filley Anna C.,Dey Mahua

Funder

National Institute of Neurological Disorders and Stroke

National Institutes of Health

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference57 articles.

1. History of oncolytic viruses: genesis to genetic engineering;Kelly;Mol Ther,2007

2. Recent progress in the battle between oncolytic viruses and tumours;Parato;Nat Rev Cancer,2005

3. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress;Liu;Nat Clin Pract Oncol,2007

4. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer;Khuri;Nat Med,2000

5. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma;Hecht;Clin Cancer Res,2003

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies;Life Sciences;2024-07

2. A new mathematical model approach on the oncolytic virotherapy potency;Journal of Mathematics and Computer Science;2024-06-26

3. Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future;Cell Communication and Signaling;2024-04-24

4. On the dynamics and optimal control of a mathematical model of neuroblastoma and its treatment: Insights from a mathematical model;Mathematical Models and Methods in Applied Sciences;2024-03-16

5. Current Role and Status for Intratumoral Injection Therapies in Metastatic Melanoma;The Cancer Journal;2024-03